Stem Cell–Derived RPE for age-related macular degeneration, a Phase 1 study. Trial Steering Committee Chair. (External organisation)

Activity: Membership › Membership of board

Description

Stem Cell–Derived RPE for age-related macular degeneration, a Phase 1 study. Trial Steering Committee Chair.
Period1 Aug 2021 → 1 Aug 2023
Held atStem Cell–Derived RPE for age-related macular degeneration, a Phase 1 study. Trial Steering Committee Chair.
Degree of RecognitionNational